Please assess the completion status of the following clinical trial:

Trial Title: Pilot Study to Evaluate The Effectiveness And Safety Of Axiom Worldwide Drx9000™ Spinal Decompression System

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female, greater than 18 years of age~* Able to understand possible risks and benefits and provide written informed consent (ICF) to the IRB approved clinical multimodal protocol~* LBP with an intensity level of greater than 4 on an eleven point numerical pain rating scale (VRS) of 0-10 (with 0 - no pain and 10 - worst possible pain)~* Completed the necessary diagnostic and medical history evaluations as described in the protocol to confirm the patient's diagnosis and eligibility for the study and DRX9000 treatment protocol.~* Willing and able to complete a six week 20 session of DRX9000 outpatient treatments and a minimum of 6 months follow-up~Exclusion Criteria:~* Pregnancy~* Evidence of neurological motor deficits on clinical examination~* Evidence of spinal cord compression, metastatic cancer, tumor, hematoma, infection or compression fracture~* Evidence of severe central stenosis with neurological deficits or nerve root entrapment~* Litigation for health-related claim (in process or pending), Worker's Compensation, or Personal Injury~* Previous spine fusion surgery, insertion of hardware or artificial disc~* Hemiplegia or paraplegia~* History of severe cardiovascular or metabolic disease, or abdominal aortic aneurysm~* Unwillingness to postpone other types of therapy for LBP during the 6 week treatment sessions~* Known alcohol abuse or drug abuse~* Height less than 4 feet 10 inches (147 cm) or greater than 6 feet 8 inches (203 cm)~* Body weight greater than 300 pounds (136 kg)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- DRX Group (Type: EXPERIMENTAL): Patients using the device DRX9000™.

Based on this trial design, predict the completion outcome and termination type (if applicable).